Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 5,084,000 | 3,364,000 | 4,749,000 | 6,066,000 | 7,211,000 |
| Cost of Goods | 1,918,000 | 1,100,000 | 1,381,000 | 1,017,000 | 952,000 |
| Gross Profit | 3,166,000 | 2,264,000 | 3,368,000 | 5,049,000 | 6,259,000 |
| Operating Expenses | 1,586,000 | 1,098,000 | 921,000 | 822,000 | 849,000 |
| Operating Income | 1,580,000 | 1,166,000 | 2,447,000 | 4,227,000 | 5,410,000 |
| Other Income | 75,000 | 51,000 | 27,000 | 2,000 | 0 |
| Pre-tax Income | 1,655,000 | 1,217,000 | 2,474,000 | 4,229,000 | 5,410,000 |
| Income Tax | 190,000 | 174,000 | 277,000 | 572,000 | 542,000 |
| Net Income Continuous | 1,465,000 | 1,043,000 | 2,197,000 | 3,657,000 | 4,868,000 |
| Net Income | $1,465,000 | $1,043,000 | $2,197,000 | $3,657,000 | $4,868,000 |
| EPS Basic Total Ops | 3.95 | 2.67 | 5.55 | 9.09 | 12.06 |
| EPS Basic Continuous Ops | 3.90 | 2.67 | 5.55 | 9.10 | 12.06 |
| EPS Diluted Total Ops | 3.77 | 2.53 | 5.24 | 8.58 | 11.29 |
| EPS Diluted Continuous Ops | 3.74 | 2.53 | 5.24 | 8.58 | 11.34 |
| EPS Diluted Before Non-Recurring Items | 3.61 | 2.53 | 5.24 | N/A | N/A |
| EBITDA(a) | $1,656,000 | $1,285,000 | $2,534,000 | $4,324,000 | $5,509,000 |